Analyst Ratings for Amedisys
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 11 analysts have published their opinion on Amedisys (NASDAQ:AMED) stock. The company has an average price target of $98.82, representing a 6.01% decrease from the previous average price target of $105.14. The majority of analysts are indifferent about the stock, with 3 bullish and 0 bearish ratings.
June 27, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Amedisys has received mixed reviews from analysts, with an average price target of $98.82, a 6.01% decrease from the previous target. This could potentially impact the stock's performance.
Analyst ratings can significantly influence a stock's performance. In the case of Amedisys, the mixed reviews and decreased price target could lead to uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100